VK2735
VK2735-302
Phase 3 small_molecule active
Quick answer
VK2735 for Weight Loss is a Phase 3 program (small_molecule) at Viking Therapeutics with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Viking Therapeutics
- Indication
- Weight Loss
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active